Precision medicine for prostate cancer-improved outcome prediction for low-intermediate risk disease using a six-gene copy number alteration classifier.
Br J Cancer
; 128(12): 2163-2164, 2023 06.
Article
en En
| MEDLINE
| ID: mdl-37120668
ABSTRACT
A multiplex 6-gene copy number classifier was used to distinguish between low- or intermediate-risk prostate cancer patients. The study analysed a cohort of 448 patients and previously published datasets from radical prostatectomies. The classifier performs better than conventional stratification methods, is low cost, and can be performed easily in clinical laboratories.
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Prostatectomía
/
Neoplasias de la Próstata
/
Medicina de Precisión
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
/
Male
Idioma:
En
Revista:
Br J Cancer
Año:
2023
Tipo del documento:
Article
País de afiliación:
Brasil